Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
531
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups

Edward LibbyDivision of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA;Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USACorrespondence[email protected]
,
David GarciaDivision of Hematology Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
,
Dulcinea QuintanaDivison of Hematology Oncology, Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
,
M. Houman FekrazadDivison of Hematology Oncology, Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA;City of Hope Medical Center, Duarte, CA, USA
,
Julie BaumanMedical Oncology, College of Medicine, University of Pittsburg Medical Center, Pittsburgh, PA, USA
,
Ala EbaidDivison of Hematology Oncology, Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
,
Robert HromasUniversity of Florida and Shands Cancer Center, Gainesville, FL, USA
,
Ian RabinowitzDivison of Hematology Oncology, Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
&
Charles WigginsNew Mexico Tumor Registry, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
 show all
Pages 2850-2857 | Received 01 Aug 2013, Accepted 19 Feb 2014, Published online: 09 May 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Ravi Kumar Gupta, Ashish Gupta, Jens Hillengass, Sarah A. Holstein, Vera J. Suman, Alankrita Taneja & Philip L. McCarthy. (2022) A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022. Expert Review of Anticancer Therapy 22:5, pages 457-469.
Read now
Iuliana Vaxman & Morie Gertz. (2019) Risk adapted post-transplant maintenance in multiple myeloma. Expert Review of Hematology 12:2, pages 107-118.
Read now
Chintan Shah, Rohit Bishnoi, Ankur Jain, Harini Bejjanki, Sican Xiong, Yu Wang, Fei Zou & Jan S. Moreb. (2018) Cardiotoxicity associated with carfilzomib: systematic review and meta-analysis. Leukemia & Lymphoma 59:11, pages 2557-2569.
Read now
Kimberly A Redic, Shannon M Hough & Erika M Price. (2016) Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor. OncoTargets and Therapy 9, pages 2783-2793.
Read now
Edward N Libby, Pamela S Becker, Nicholas Burwick, Damian J Green, Leona Holmberg & William Ira Bensinger. (2015) Panobinostat: a review of trial results and future prospects in multiple myeloma. Expert Review of Hematology 8:1, pages 9-18.
Read now

Articles from other publishers (11)

Mary Steinbach, Karun Neupane, Muhammad Aziz, Wade Lee-Smith, Kelley Julian, Amandeep Godara, Brian McClune, Amar H. Kelkar, Douglas Sborov & Ghulam Rehman Mohyuddin. (2023) Multiple Myeloma in Young Patients: A Scoping Review. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Sikander Ailawadhi, Ricardo D. Parrondo, Navnita Dutta, Bing Han, Gina Ciccio, Yesesri Cherukuri, Victoria R. Alegria, Betsy R. LaPlant, Vivek Roy, Taimur Sher, Brett Edwards, Stephanie Lanier, Alak Manna, Keisha Heslop, Thomas Caulfield, Emir Maldosevic, Peter Storz, Rami Manochakian, Yan Asmann, Asher A. Chanan-Khan & Aneel Paulus. (2023) AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma. Cancers 15:2, pages 477.
Crossref
Xiaomin Chen, Jiayue Liu, Jialin Duan, Hao Xiong, Yang Liu, Xinwen Zhang & Chunlan Huang. (2022) Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis. BMC Cancer 22:1.
Crossref
Luis Gerardo Rodríguez‐Lobato, Arturo Pereira, Carlos Fernández de Larrea, Maria Teresa Cibeira, Natalia Tovar, Raquel Jiménez‐Segura, David F. Moreno, Aina Oliver‐Caldés, Laura Rosiñol & Joan Bladé. (2021) Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period. British Journal of Haematology 196:3, pages 649-659.
Crossref
Marwa Tantawy, Lakshmi Manasa Chekka, Yimei Huang, Timothy J. Garrett, Sonal Singh, Chintan P. Shah, Robert F. Cornell, Rachid C. Baz, Michael G. Fradley, Nida Waheed, David L. DeRemer, Lihui Yuan, Taimour Langaee, Keith March, Carl J. Pepine, Jan S. Moreb & Yan Gong. (2021) Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis. Frontiers in Cardiovascular Medicine 8.
Crossref
Ting Zhang, Bo Li, Qilin Feng, Zhijian Xu, Cheng Huang, Huiqun Wu, Zhangbo Chen, Liangning Hu, Lu Gao, Peng Liu, Guang Yang, Hui Zhang, Kang Lu, Tingye Li, Yi Tao, Xiaosong Wu, Jumei Shi & Weiliang Zhu. (2019) DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma. Acta Biochimica et Biophysica Sinica 51:5, pages 517-523.
Crossref
Douglas E Joshua, Christian Bryant, Caroline Dix, John Gibson & Joy Ho. (2019) Biology and therapy of multiple myeloma. Medical Journal of Australia 210:8, pages 375-380.
Crossref
Morgane Mounier & Marc Maynadié. (2019) Les néoplasies plasmocytaires et autres dysglobulinémies en population générale. Revue Francophone des Laboratoires 2019:511, pages 28-33.
Crossref
Rachid Baz, Syeda Mahrukh Hussnain Naqvi, Jae‐Hoon Lee, Jason Brayer, Nancy Hillgruber, Brooke L. Fridley, Kenneth H. Shain, Daniel M. Sullivan & Melissa Alsina. (2018) Lenalidomide‐based response‐adapted therapy for older adults without high risk myeloma. British Journal of Haematology 184:5, pages 735-743.
Crossref
Chintan Shah, Rohit Bishnoi, Yu Wang, Fei Zou, Harini Bejjanki, Samip Master & Jan S. Moreb. (2018) Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials. Oncotarget 9:34, pages 23704-23717.
Crossref
Muhammad A. Mir, Prashant Kapoor, Shaji Kumar, Shivlal Pandey, Angela Dispenzieri, Martha Q. Lacy, David Dingli, William Hogan, Francis Buadi, Suzanne Hayman, Manish Gandhi & Morie A. Gertz. (2015) Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic. Clinical Lymphoma Myeloma and Leukemia 15:6, pages 349-357.e2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.